HOME >> BIOLOGY >> NEWS
Risk of ectopic pregnancies after IVF declines with age in women with tubal disease

Madrid, Spain: The first study to look at the risk of ectopic [1] pregnancies after IVF in a complete national ART register has unearthed a surprising result, a conference of international fertility experts heard today (Tuesday 1 July).

The researchers found that women face a slightly increased risk of ectopic pregnancies after IVF. More surprisingly, they found that whereas in the normal population the risk of an ectopic pregnancy increases with women's age, after IVF the risk decreases with age in women who have had diseased Fallopian tubes.

Elizabeth Asung, an honorary research fellow at Leeds University and The Bridge Centre in London, UK, told the annual conference of the European Society of Human Reproduction and Embryology that she had analysed data from the UK's Human Fertilization and Embryology Authority (HFEA) on 97,240 women, aged between 18-50 who underwent either straightforward IVF embryo transfer (IVF-ET) or embryo transfer after ICSI (ICSI-ET) between 1991 and 1999.

She and her colleagues found that after ICSI-ET the incidence of ectopic pregnancies was 1.3% a figure that places it firmly in the range of incidence in the normal population. However, after IVF-ET the numbers increased by roughly a half from between 1-2% in the normal population to 2.8%.

Ms Asung said: "The difference in the numbers of ectopic pregnancies after IVF-ET and ICSI-ET may be because with ICSI the women tend to have no or fewer abnormalities associated with infertility because it's the man's fertility that is at issue. Whereas with IVF there's a higher proportion of women with compounding problems such as tubal disease, which may be contributing to their infertility and which are risk factors for ectopic pregnancies."

The study found that when women's Fallopian tubes had been damaged by tubal disease, the numbers of ectopic pregnancies increased to 6.1% in women under the age of 25, 4.1% between 25 and 29, 3.9% between 30 a
'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-1376-563090
European Society for Human Reproduction and Embryology
1-Jul-2003


Page: 1 2 3

Related biology news :

1. Marijuana use could cause tubal pregnancies
2. Study finds two-thirds of unplanned pregnancies in women using contraception
3. Component in plastic bottles found to cause abnormal pregnancies in mice
4. Researchers concerned over early egg retrieval after cancer treatment - doctors advised to monitor pregnancies as mice study reveals problems
5. Ringling Bros. announces four Asian elephant pregnancies at Center for Elephant Conservation
6. Common enzyme deficiency may jeopardize pregnancies
7. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
8. Why your knees and quads hurt more after running than walking: Youre only human
9. Fluid derived from aloe plant prolongs life after hemorrhagic shock in animal study
10. Researchers find that color perception is not innate, but acquired after birth
11. Reading hexametric rhyme supports cardiac synchronization, especially after a heart attack

Post Your Comments:
(Date:8/22/2014)... the birds and the bees. But that old ... fertilized. The fertilization process for flowering plants is ... male and female reproductive cells. New research from ... Munich, and including Carnegie,s Wolf Frommer, David Ehrhardt, ... signaling process that guides flowering plant fertilization. It ...
(Date:8/21/2014)... -- Nxt-ID, Inc. (OTCQB: NXTD), a biometric authentication company ... that its shares of common stock and the warrants ... proposed underwritten public offering of common stock and warrants ... Market, subject to closing of its proposed underwritten public ... trade under the symbol "NXTD" and "NXTDW," respectively. ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- LiveScan Service ... agreed to a partnership with Gabriel Health Institute, ... fastest growing Certified Nursing Assistant preparatory schools. ...  an exclusive member of Binary,s LiveScan service provider,s ... will improve its service capabilities by widening ...
Breaking Biology News(10 mins):Calcium and reproduction go together 2Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 2LiveScan Provider Binary Biometrics Announces Partnership with Preeminent CNA School, Gabriel Health Institute to Expand Services in Orlando Region 3
(Date:8/21/2014)...  BioSpecifics Technologies Corp. (NASDAQ: BSTC ... collagenase-based products marketed as XIAFLEX ® (collagenase ... XIAPEX ® in the EU, today announced ... Phase 2a study of CCH for the potential ... results showed that all three doses of CCH ...
(Date:8/21/2014)... DUBLIN, Ireland , August 21, 2014 ... and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone ) has announced the ... Market 2014-2018"  report to their offering.  ... also known as hormone therapy, is a ... longer being produced by the body. This ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 Mathematic ... at Harvard University , and funded by the ... aggressive cells within tumors can be visually identified for elimination. ... tumor,s growth. The study, which shows a topological map of ... needed time in cancer research, for while tumor cells can ...
(Date:8/21/2014)... Ontotext S4 , The Self ... . Now the same enterprise hardened text mining, ... unstructured data is available to start-ups and mid-size businesses ... Organizations that do not have resources to evaluate and ... S4 since there is no need for on premise ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
Cached News: